Author: ThomasS111
Creative Diagnostics Launches Comprehensive Solutions for Antiviral Testing with Diverse Animal Models
Creative Diagnostics announces its comprehensive portfolio of Animal Models for Antiviral Testing. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics announces its comprehensive portfolio of Animal Models for Antiviral Testing. This suite of services offers researchers a vital tool in the fight against viruses, accelerating the development of new vaccines and antiviral therapies. Viruses are notorious for their ability to instigate widespread health crises that seriously affect human health. They can cause a wide range of diseases, including hemorrhagic, gastrointestinal, pharyngeal and neuroinvasive infections. To effectively combat these diseases, it is critical to understand the biology…
Creative Diagnostics Announces Anti-Chimeric Antigen Receptor Linker Antibodies for Streamlined CAR Detection
Creative Diagnostics announces the launch of its Anti-Chimeric Antigen Receptor Linker Antibodies for CAR detection. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the launch of its Anti-Chimeric Antigen Receptor Linker Antibodies, including G4S linker antibodies and Whitlow 218 linker antibodies. These novel tools empower researchers to develop next-generation CAR T-cell therapies with a more efficient and specific method for CAR detection. Considered a major scientific breakthrough in cancer immunotherapy, chimeric antigen receptor (CAR) T-cell therapy works by reengineering cell surface receptors. To date, two clinically approved CAR T-cell therapies (Kymriah® and…
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics is proud to announce Plaque Reduction Assay services to support antiviral research. As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive suite of Plaque Reduction Assay services to support antiviral research. These new solutions offer researchers a powerful and well-established method for evaluating the efficacy of antiviral compounds. Normal cells can absorb reactive dyes during metabolism, but when the cells are infected with a virus, they lose their ability to absorb the dye, resulting in the formation of colorless plaques. When a virus is neutralized by…
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics announces its new line of Norovirus VLP Antigens for in vitro diagnostics and vaccine research. Creative Diagnostics, a leading manufacturer and supplier of antibodies, antigens and assay kits, is pleased to announce the availability of its new line of Norovirus VLP Antigens to accelerate in vitro diagnostics and vaccine research. These new antigens have been validated to a high level of confidence using electron microscopy. Norovirus is a non-enveloped, positive-sense, single-stranded RNA virus of the family Caliciviridae and is the leading cause of non-bacterial acute gastroenteritis worldwide. The infection is characterized by non-bloody diarrhea, vomiting and abdominal pain. The stability…